Time for action against antimicrobial resistance
Interviewee/Contributor
Lars Rebien Sørensen
Organisation
Novo Nordisk Foundation
Antibiotics
Exploring new business models for antibiotics
Interviewee/Contributor
Heather Graz
Organisation
Neem Biotech Ltd
Building the antibiotic pipeline
Interviewee/Contributor
Wes Kim
Organisation
The PEW Charitable Trusts
Meeting Report: Funding rises for early assets
Interviewee/Contributor
Søren Møller
Organisation
Novo Seeds
Sourcing antibiotics from the nematode worm
Interviewee/Contributor
Philippe Villain-Guillot
Organisation
Nosopharm SAS
Assessing the threat from drug-resistant bacteria
Interviewee/Contributor
Jennifer Schneider
Organisation
Tiber Creek Partners LLC
WHO identifies bacteria posing the greatest threat
Interviewee/Contributor
Neil Miller
Organisation
Auspherix Ltd
The stately progress of antibiotics
Interviewee/Contributor
Victoria English
Organisation
MedNous
Fighting bacterial infection with phage therapy
Interviewee/Contributor
Bjorn Herpers
Organisation
Micreos BV
Getting traction against antimicrobial resistance
Interviewee/Contributor
Dawn Firmin
Organisation
MGB Biopharma Ltd